泽璟制药：预计2025年净利润亏损1.4亿元至1.91亿元

Core Viewpoint - Zejing Pharmaceutical announced an expected net profit attributable to the parent company for the year 2025 to be between -191 million yuan and -140 million yuan, indicating an increase in losses compared to the same period last year by 1.7692 million to 5.3592 million yuan [1] Financial Performance - The company anticipates achieving an operating revenue of 796 million to 829 million yuan for the year 2025, representing a year-on-year increase of 49.45% to 55.55% compared to the previous year [1]